|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
2/2005
vol. 107 abstract:
Review paper
Levofloxacin (Oftaquix) a fluoroquinolone of a new generation in prevention of the postoperative endophthalmitis following uncomplicated cataract surgery – the study of the European Society of Cataract and Refractive Surgeons (ESCRS)
Justyna Izdebska
1
,
Jacek Szaflik
1
Klinika Oczna 2005, 107(4-6): 344-347
Online publish date: 2005/07/02
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Randomised multi-centre european clinical trial of antibiotic prophylaxis for endophthalmitis following cataract surgery – study has just begun in Poland. Poland is joining one of the largest prospective european clinical study of antibiotic prophylaxis and the largest in ophthalmology – the ESCRS endophthalmitis prophylaxis clinical trial. Up to 35 000 cataract patients are going to be recruited for this randomized, controlled, multi-centre study in 16 centres from 10 european countries. The goal is to reduce the incidence of endophthalmitis after cataract phacoemusification in Europe to less than 0.05% (less than 1 per 2 000 surgeries). The patients will be divided into four groups; different regimes of two antibiotics: cefuroxime injected intra-camerally and levofloxacine eye drops topically will be compared.
keywords:
endophthalmitis, cataract surgery, clinical trial, ESCRS, cefuroxime, levofloxacin |
|
POLSKI
